Mid-term results of sub-trochanteric valgus osteotomy for symptomatic late stages Legg-Calvé-Perthes disease

• Published in: World journal of orthopedics 2023-05, Vol.14 (5), p.328-339
• Main Authors: Emara, Khaled M, Diab, Ramy Ahmed, Emara, Ahmed K, Eissa, Mohamed, Gemeah, Mostafa, Mahmoud, Shady Abdelghaffar
• Format: Article
• Language: English
• Subjects: Retrospective Study
• ISSN: 2218-5836; 2218-5836
• DOI: 10.5312/wjo.v14.i5.328

The treatment of late stages of Legg-Calvé-Perthes disease (LCPD) is controversial. Although the concept of femoral head containment is a well-established technique of treatment, its use remains debatable in the late stages of the disease, as it does not improve symptoms in terms of limb length discrepancy and gait. To assess the results of subtrochanteric valgus osteotomy in symptomatic patients with late-stage Perthes disease. From 2000 to 2007, 36 symptomatic patients with late stage of Perthes disease were surgically treated with subtrochanteric valgus osteotomy and followed-up for 8 to 11 years using the IOWA score and range of motion (ROM) variables. The Mose classification was also assessed at the last follow-up to reflect possible remodeling. The patients were 8 years old or older at the time of surgery, in the post-fragmentation stage, and complaining of pain, limited ROM, Trendelenburg gait, and/or abductor weakness. The preoperative IOWA score (average: 53.3) markedly improved at the 1-year post follow-up period (average: 85.41) and then slightly improved at the last follow-up (average: 89.4) ( value < 0.05). ROM improved, with internal rotation increased on average by 22° (from 10° preoperatively to 32° postoperatively) and abduction increased on average by 15.9° (from 25° preoperatively to 41° postoperatively). The mean Mose deviation of femoral heads was 4.1 mm at the end of the follow-up period. The tests used were the paired -test and Pearson correlation test, where the level of significance was a value less than 0.05. Subtrochanteric valgus osteotomy can be a good option for symptomatic relief in patients with late-stage of LCPD.